COLUMBUS, Ga. and PISCATAWAY, N.J., Jan. 31, 2018 -- IACT Health, a clinical trial management company dedicated to streamlining study operations for highly efficient clinical trials, and Alpha Clinical Systems, the leading provider of affordable and comprehensive next-generation eSource solutions, today announced that IACT Health has selected Alpha Clinical Systems’ ACS360 eSource platform for clinical trial data capture.
Alpha Clinical Systems will provide the fully-integrated ACS360 platform, including Study Designer and ez-SourceDocx. Using the ACS360 platform, IACT Health will streamline study start-up and execution with web-based study design and tablet-based direct eSource data capture. The ACS360 platform is designed to help streamline study operations by providing truly paperless data capture and real-time access to validated study data, dramatically reducing study timelines and costs.
“IACT Health is excited to begin working with Alpha Clinical Systems in an effort to further streamline study operations via their next-generation ACS360 eSource platform,” said Christine Senn, CIO, IACT Health. “We selected the ACS360 platform because we required an eSource solution that was both comprehensive and affordable, and could deliver real-time, remote access to high-quality study data.”
“IACT Health required a more comprehensive, yet affordable, eSource solution that would streamline and modernize their clinical trials,” said Murthy Gandham, CEO, Alpha Clinical Systems. “We look forward to helping IACT Health deliver high-quality data in real-time via the ACS360 platform.”
Alpha Clinical Systems developed the ACS360 platform to eliminate the challenges of eSource adoption among life science companies. Designed to maximize site efficiency and data quality, the ACS360 platform works with or without existing electronic data capture (EDC) systems to deliver real-time, remote access to validated clinical trial data.
About IACT Health
IACT Health is a wholly owned clinical research company with multispecialty sites across Georgia. We pride ourselves on providing the highest level of quality care for patients, and our guarantee of optimal results for CROs, sponsors, and physicians. The IACT Health name stands for excellence. From the way in which we operate clinical research sites, to the agnostic nature of our clinical trial approach, to our stanch focus on enhancing the speed and accuracy of research data, we are known to represent the highest level of care, accountability and progress.
About Alpha Clinical Systems
Founded in 2009, Alpha Clinical Systems (ACS) is the leading provider of affordable and comprehensive next-generation eSource solutions. Developers of ACS360, a fully-integrated, cloud-based platform that provides direct eSource data capture with or without existing EDC systems. Working with small to mid-side sites, sponsors and CROs, Alpha Clinical Systems is dedicated to facilitating more widespread eSource adoption among life sciences companies. For more information visit us online at alphaclinicalsystems.com.
Media Contact:
Alicia Maguire
Alpha Clinical Systems
267.319.2093
[email protected]


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Instagram Outage Disrupts Thousands of U.S. Users
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



